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v Abstract

INTRODUCTION
In the context where current strategies employed by health professionals are not able to
slow the increasing rates of obesity, diabetes mellitus and insulin resistance, collectively
known as the insulin resistance syndrome (metabolic syndrome, syndrome X),
evidence-based practice is central to implementing appropriate and targeted guidelines
to the individual. The central hypothesis argued here is that for evidence based practice
to have relevance there is value in collecting this evidence from both quantitative and
qualitative research methodologies. The aim of this thesis is to explore a number of
aspects of research that produce evidence for the management of diet related disease. It
uses as a reference point, a randomised controlled trial investigating the feasibility and
efficacy of the incorporation of high amylose maize resistant starch on clinical, and
dietary outcomes in an overweight sample of the population. Current research aims to
develop the optimal nutrient mix for the insulin resistance syndrome, however, the
challenge and focus now should be to make the benefits achievable in the ‘real world’
(Storlien, Tapsell, Fraser, Leslie, Ball, Higgins, Helge and Owen 2001). To this end, a
rigorous framework addressing dietetic and lifestyle issues was included in the
randomised controlled trial.

The nutrient of choice for the intervention trial was resistant starch (RS); a form of
carbohydrate that reaches the lower gastrointestinal tract undigested and is consequently
fermented. Resistant starch is composed of two polysaccharide forms; amylose and
amylopectin. The beneficial effects are particularly evident from the amylose form
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compared to the more readily digested amylopectin. It demonstrates probiotic and
dietary fibre-like characteristics hypothesised to be beneficial for people with the insulin
resistance syndrome, hypercholesterolaemia and colon cancer due to its reduced
availability as a source of energy, reduced energy density and its ability to lower colonic
pH. Therefore RS has potential to be used in the dietary management for reducing risk
factors for the insulin resistance syndrome.

METHODOLOGY
Three preliminary studies were performed to enable the accurate recording of
significant lifestyle variables. The first employed sociolinguistics to conceptualise how
and why inaccuracy in reporting of dietary intake occurs. Secondly, a lifestyle history
questionnaire was developed to examine possible sources of baseline variation between
subjects in the study. Finally, an intervention trial survey was designed to analyse
subject’s experiences post-intervention such as barriers to adherence.

Following these, a dietary intervention trial was conducted in overweight (BMI: 2535kg/m2) adult volunteers. Subjects with any of the following were excluded: diabetes
mellitus (fasting blood glucose level ≥ 6.1mmol/L), known hypercholesterolaemia or
hypertension, inflammatory bowel disease, coeliac disease, renal disease, current
smokers, pregnancy and those reporting a significant weight change in the previous 6
months. Twenty-five volunteers were randomly assigned to receive advice on either a
diet high in RS or to a control diet low in RS. Control groups were maintained at a level
of 6 grams of various types of RS, based on the Australian average consumption, while
the RS group received 25 grams of RS derived from commercially manufactured RS
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containing an high amylose to amylopectin ratio.

Subjects recorded foods used to achieve differences in RS using a daily checklist form.
Foods recorded on daily checklist forms were analysed by counting. Repeated diet
history (DH) interviews were performed in weeks 0, 3, 6, 9 and 12. Dietary data were
entered into a nutrient analysis software package, FoodWorks (v2.10.136, Xyris
Software, Highgate Hill, Brisbane) for further statistical comparisons. To estimate the
accuracy of reporting dietary intakes the ratio of reported energy intake to estimated
basal metabolic rate (BMR) was calculated. This method provides an index for
comparison with cut-off limits that assess the validity of the reported energy intakes.

Baseline metabolic and biochemical indicies were compared to those at 12 weeks after
intervention. Insulin resistance was measured by hyperinsulinaemic euglycaemic clamp.
Fasting respiratory quotient (RQ) and resting metabolic rate (RMR) was measured by
indirect calorimetry. Fasting plasma glucose, insulin, triglycerides, total cholesterol,
high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol were
measured by standard assays. Body mass index (BMI) was calculated by weight in
kilograms divided by height in meters squared and body composition was assessed by
dual-energy x-ray absorptiometry (DXA).

In the same subjects the acute response to RS diets and control diets were performed by
a meal challenge (breakfast and lunch) at 12 weeks. The following variables were
collected from participants while fasted and then postprandially on an hourly basis
thereafter: RQ, RMR, plasma glucose, insulin, triglyceride excursions and satiety.
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Statistical comparisons were made within groups initially and on completion and
between groups over time using a statistical software package, JMP (Version 3.2, SAS
institute Inc, Cary NC, 1989-1996).

In addition, as derived from the preliminary studies, subjects completed lifestyle history
questionnaires initially in week 0 and an intervention trial survey at 12 weeks. Survey
responses were reviewed using content analysis to identify themes and applying a
ranking of significance based on frequency of their occurrence.

RESULTS
Of the twenty-five subjects randomly assigned with random numbers to a high or low
amylose-rich RS diet, twenty-two completed the trial. Twenty of these were classified
as insulin resistant. The two subjects who were not insulin resistant had been randomly
assigned to the high RS diet group. The discontinuing participants caused groups to
become mismatched for gender, BMI and HDL cholesterol. In addition this caused the
RS and control groups to be significantly different for insulin sensitivity with a mean
and standard deviation of 6.01 ± 0.79 versus 3.51 ± 0.42 mg/kg.min respectively at
week 12 (p=0.006). There were no significant effects of 12 weeks intervention with
control or RS diets on body composition (% change in body fat 6.3 versus 1.7
respectively, p>0.05) and metabolic variables (change in insulin sensitivity 2.8% versus
–8.4% respectively, p>0.05) despite reported compliance to the dietary goals for
intervention foods.
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Assessment of the meal challenges displayed a smaller rise in glucose excursion in
response to the RS pretreated group challenged with either low or high RS meals. The
differences between fasting glucose response to a breakfast meal was significantly
affected by the intervention diet (p=0.016). There was also a significant effect of test
meal composition on insulin excursion reflecting an increased insulin response to low
RS meals in both groups (p=0.04). The remaining variables measured during meal
challenges were not significantly affected by meal composition or intervention diet.

The lifestyle history questionnaire identified several variables, such as weight cycling
and level of physical activity in the intervention group that may produce variation in
response and further may explain the equivocal results. The final survey confirmed
previous reports that individualised treatment is more effective and that the provision of
foods in an intervention trial enhances compliance to dietary regimens.

The preliminary study of diet history interviews emphasised the need for the interviewer
to listen for verbal cues such as “probably” and “it depends”. These were most
prominently identified in relation to energy dense foods and thereby assisted the
interviewer in obtaining more accurate dietary descriptions. Visual displays of food
quantities also needed to be available for more precise reporting of problematic meals to
recount such as dinner. The diet history interview data collected during the intervention
trial indicated a mean score for valid reporting for weeks 0, 3, 6 and 9, though greater
under-reporting resulted in a decline in validity at week 12.
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DISCUSSION
After 12 weeks the lack of significant differences between control and intervention
groups in terms of changes in body composition, serum lipids, substrate utilisation and
fasting plasma glucose/insulin levels suggested that, at least with this profile of subjects,
there is no effect of habituation with 25g RS in the diet. This may reflect the impact of
dosage (25g RS estimated for bowel health may not be enough for metabolic health),
the small sample size of the study and/or attrition rates. An increase in insulin resistance
of about 10% in the RS group was consistent with the data (mean change = -9.8%; 95%
confidence limit: 29 + 9) however, approximately 40 subjects would have been required
to detect an effect of this magnitude using the current protocol. A reduction in the
insulin excursion when challenged with the high RS meals was reasonable considering
what is known about RS metabolism, however this significant result was not reflected in
the glucose values overall, nor did it translate to a metabolic benefit from chronic
exposure. Overall, with the consumption of relatively moderate quantities of RS, and
given that reported meal patterns and intakes of some nutrients varied over the duration
of the trial, the metabolic effect could be explained by a variety of differentials.

Human metabolic and behavioural variability are significant factors to consider in trials
establishing the evidence for the optimal nutrient mix for the metabolic syndrome. First,
there is diversity among humans in their genetic predisposition to disease. Second there
are numerous points within a clinical trial where error in measurements may occur.
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In current practice clinicians are asked to support their approach to the management of
diet related disease with evidence-based guidelines. To date the most recognised form
of best evidence is in the RCT, which presents limitations in relation to assessing the
effect of dietary intake on the management of chronic disease as demonstrated here. The
results of the thesis reported here using a RCT as its basis and made relevant to the ‘real
world’ through the collection of naturalistic practice based evidence, showed that the
effects of high amylose RS on the insulin resistance syndrome were equivocal. The
reasons for this may be explained in the way in which outcomes were measured and
assessed.

Results from the preliminary work on the collection of dietary data supported the need
for research that studies the way outcomes are measured and assessed. The verbal
descriptors used by participants were shown to correlate with their difficulty in
reporting accurate food intake. This thesis demonstrates that problematic reporting of
caloric intake was typically associated with energy dense foods. As diet-disease
relationships need accurate recording of dietary intake to demonstrate cause and effect,
qualitative studies such as this are fundamental to improving accurate gathering of
energy intake. The methods developed here for identifying accurate reporting and
applied to this randomised controlled intervention trial can be used in further trials and
applied to clinical practice.

Results gained in clinical trials of dietary manipulation need to be able to be reproduced
in the real world to have significant outcomes on the incidence of type 2 diabetes and
the metabolic syndrome. Hence, to establish the evidence for practice in medical
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nutrition therapy1 information from both objective scientific2 research and naturalistic3
observations have been collected and analysed. Holistic patient care is necessary if
individuals are to adapt recommended dietary guidelines to their modern lifestyle.
Despite limitations in the relatively short duration of the RCT presented here, it serves
as a template to analyse the outcomes of dietary intervention in the long term. To prove
RS as a therapeutic dietary agent in the control of risk factors for the insulin resistance
syndrome, further investigations using combined methodologies are indicated.

1

Medical Nutrition Therapy refers to the application of nutrition knowledge and clinical data in the management of

diet-related disease using an evidence based approach (Franz 2003)
2

Scientific – The scientific (positivist) paradigm uses a reductionist stance, examining mostly laboratory-based

interventions with a predetermined question of causality between stable, tangible variables (Guba and Lincoln 1981
and 1985).
3

Naturalistic – With regards to the experimental environment in human feeding research, naturalistic research studies

the free-living environment. Naturalistic implies a less precise, less accurate and less controlled evidence though
greater in ecological relevance when compared to intervention or laboratory formed evidence. They are constructed
in the natural environment where behaviour is less disrupted, there are no controlled manipulations and allow for a
variable environment (Blundell and Stubbs 1997).
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vi Structure of the thesis
Well-recognised confounders in human based research vastly dictate the challenge in
establishing sound evidence-based practice. These aspects reflect the reality of human
variability, the need for individualised therapies and the existence of lifestyle derived
confounders such as diet and activity levels and the problems associated with gathering
information on these factors. The challenges raised form the ambiance for this thesis,
taking the theoretical position that establishing the evidence from a dietetic perspective
must draw on the scientific and naturalist dichotomies in the research context. Current
human research does not commonly combine these modalities of analysis. The RCT is
positioned as high-level evidence, yet inadequately captures less tangible attributes of
human variability that naturalistic research can identify. The reductionist approach
enforced by a RCT does not detect or accommodate for non-quantifiable and often
significant personal environmental barriers to individual adoption of recommended
lifestyle modifications. However, non-RCT forms of research are often perceived to be
insufficient in rigor and robustness to base clinical practice upon.

The RCT, the accepted design for establishing evidence based practice, is of limited
value on its own. This is because the extent of human variability from both biological
and social influences makes it difficult for studies of a size feasible in practice to
produce definitive results where biological outcomes are tested. Evidence based practice
would benefit from research that includes both qualitative and quantitative
methodologies so that practitioners have a range of information on which to base their
decisions.
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This thesis hypothesises that researchers should provide naturalist evidence in a
complimentary fashion when researching diet-disease relationships with more widely
accepted scientific (positivist) high-level evidence such as the RCT for appropriate
integration into clinical practice. This hypothesis is tested through a RCT complimented
by observational naturalistic research. The diet-disease relationship chosen for this
comparison and testing was carbohydrate manipulation in an overweight insulin
resistant population.
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